原发性系统性硬化症心脏受累的定义:一项范围综述
该范围综述检索MEDLINE、EMBASE和PubMed共2436条记录,最终纳入295篇以系统性硬化症心脏受累(SHI)为主要研究内容的文献,旨在梳理既往使用的SHI定义及测量条目。分析发现研究质量参差、患者数量普遍较少且SHI定义高度异质,文献对SHI范围和亚临床检查异常预后意义缺乏共识。作者结论认为缺乏标准化SHI定义是系统性硬化症的重要未满足需求。
要点
- 系统性硬化症心脏受累(SHI)尚无共识定义,文献中定义高度异质。
- 已发表研究质量参差、患者数量普遍较少。
- 亚临床检查异常的预后意义在文献中缺乏明确共识。
核心结论
- 缺乏标准化SHI定义仍是系统性硬化症的重要未满足需求。
- 本综述结果将有助于制定共识分类标准,以更准确量化SHI负担、识别SHI发生风险增加相关因素并评估新治疗策略疗效。
研究设计与样本
- 范围综述,检索MEDLINE、EMBASE和PubMed数据库共识别2436条记录,最终纳入295篇以SHI为主要研究内容的已发表文章。
- 提取既往使用的SHI定义及用于测量SHI的条目,并记录任何报告与SHI风险增加相关的因素。
主要发现
- 纳入研究质量参差、患者数量普遍较少,且研究内SHI定义高度异质。
- 文献对SHI的范围及常见检出的亚临床检查异常的预后意义缺乏明确共识。
临床怎么用
- 临床识别SHI时需注意现有文献定义不统一,尚无共识分类标准可供直接采用。
- 亚临床检查异常的预后意义尚不明确,解读时需谨慎。
局限性
- 纳入研究质量参差、患者数量普遍较少且SHI定义高度异质,限制证据汇总。
- 文献缺乏对SHI范围和亚临床异常预后意义的共识。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Clinically evident primary heart involvement due to systemic sclerosis (SHI) is considered a poor prognostic factor and is a leading cause of systemic sclerosis (SSc) related death. Yet, there remains no consensus definition of SHI and poor understanding of the natural history and risk factors for the development of SHI. METHODS: We performed a scoping literature review of published articles with a primary focus of SHI to capture previously used definitions of SHI and items used to measure SHI. Any factors reported to be associated with an increased risk of SHI were recorded. RESULTS: Of the 2436 records identified in a search of MEDLINE, EMBASE and PubMed databases, 295 were included in the final scoping review. Analysis of the literature revealed studies of variable quality, generally low patient numbers and highly heterogeneous definitions of SHI within studies. There is no clear consensus from the literature as to the scope of SHI and the prognostic significance of sub-clinical investigation abnormalities commonly detected. CONCLUSION: The lack of a standardised definition of SHI remains a significant unmet need in SSc. The results of this review will assist in the development of consensus classification criteria to enable more accurate quantification of the burden of SHI, identification of factors associated with increased risk of developing SHI, and evaluation of the efficacy of any novel therapeutic strategies.
引用
- Ross L, Prior D, Proudman S, et al. Defining primary systemic sclerosis heart involvement: A scoping literature review. Semin Arthritis Rheum. 2018. PMID: 30170705. doi:10.1016/j.semarthrit.2018.07.008
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。